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ABSTRACT
Introduction Chronic non- specific low back pain is 
a major public health problem. Evidence supports the 
effectiveness of exercise as an intervention. Due to 
a paucity of direct comparisons of different exercise 
categories, medical guidelines were unable to make 
specific recommendations regarding the type of exercise 
working best in improving chronic low back pain. This 
network meta- analysis (NMA) of randomised controlled 
trials aims to investigate the comparative efficacy of 
different exercise interventions in patients with chronic 
non- specific low back pain.
Methods and analysis MEDLINE, Scopus, Cochrane 
Central Register of Controlled Trials, Physiotherapy 
Evidence Database, SPORTDiscus,  Clinicaltrials. gov and 
the WHO International Clinical Trials Registry Platform 
search portal were searched on November 2019 and 
without language restrictions. The search will be updated 
after data analysis. Studies on adults with non- specific 
low back pain of at least 12 weeks duration comparing 
exercise to either no specific intervention (ie, no treatment, 
wait- list or usual care at the treating physician’s 
discretion) and/or functionally inert interventions (ie, 
sham or attention control interventions) will be eligible. 
Pain intensity and back- specific disability are defined 
as primary outcomes. Secondary outcomes will include 
health- related physical and mental quality of life, work 
disability, frequency of analgesic use and adverse events. 
All outcomes will be analysed short- term, intermediate- 
term and long- term. Data will be extracted independently 
by two review authors. Risk of bias will be assessed using 
the recommendations by the Cochrane Back and Neck 
Group and be based on an adaptation of the Cochrane Risk 
of Bias tool.
Ethics and dissemination This NMA will be reported 
in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses_NMA checklist. 
The results will be presented in peer- reviewed journals, 
implemented in existing national and international 
guidelines and will be presented to health care providers 
and decision makers. The planned completion date of the 
study is 1 July 2021.
PROSPERO registration number CRD42020151472.
INTRODUCTION
With a lifetime prevalence of about 75%,1 low 
back pain is a major public health problem. 
Up to 30% of the population experience 
such pain per year.2–4 In 2015, more than 
530 million people were suffering from low 
back pain worldwide (7211 per 100 000 
persons), which indicates an increase of 
17.3% (16.5%–18.2%) from 2005 to 2015.4 
With more than 60 million disability- adjusted 
life years in 2015, low back pain has become 
one of the leading causes of disability world-
wide, placing a major burden on individuals 
and healthcare system.1 5 6
Current evidence supports the effec-
tiveness of exercise as an intervention for 
chronic non- specific low back pain.7 Exer-
cise generally seems to decrease pain and to 
improve function and quality of life in this 
patient population.7 8 Exercise is regarded 
as a primary intervention for chronic non- 
specific low back pain in most international 
medical guidelines.7–9 However, exercise is 
Strengths and limitations of this study
 ► This network meta- analysis (NMA) will investigate 
the comparative efficacy of different types of exer-
cise in order to offer an evidence- based synthesis 
that will integrate the actual recommendations, 
balancing values and preferences of patients and 
stakeholders.
 ► Evidence that can be drawn from a NMA is limited 
and can only be interpreted with caution.
 ► To avoid heterogeneity and inconsistency the defi-
nition of nodes (grouping of interventions) needs 
careful consideration.
 ► The interpretation of evidence from indirect compar-
isons is limited.
 ► Evidence drawn from ranking analysis is limited.
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an umbrella term for a very heterogeneous field of inter-
ventions with various mechanisms of action.10 Neverthe-
less, different categories of exercise have shown at least 
some effectiveness for low back pain.11–14 Due to a paucity 
of direct comparisons of different exercise categories, 
medical guidelines were unable to make specific recom-
mendations regarding which type of exercise works best 
in improving chronic low back pain.8 9 Medical guidelines 
thus recommend basing the choice between different 
types of exercise on availability and the patients’ and ther-
apists’ preferences rather than evidence.8 9
For example, the National Institute for Health and 
Care Excellence (NICE) guideline NG59 about low back 
pain and sciatica8 states that ‘the Guideline Develop-
ment Group found it difficult to tease out which type of 
exercise modality was effective’. The guideline’s authors 
agreed that it would be useful to recommend an inter-
vention that the person with back pain would be likely to 
participate in and that promotes self- management.
The 2017 German National Disease Management 
Guideline for Non- Specific Low Back Pain9 states that 
exercise therapy is more effective than usual care or 
passive treatment options.15 Strengthening the muscles 
and stabilisation reduces the symptoms and enable the 
patient to return to work more quickly.16 17 However, 
evidence is lacking for what type of exercise is the most 
effective. Hence, in absence of a precise recommendation 
on which type of exercise is to be used in clinical practice, 
the health professionals can decide the type of treatment 
based on their preferences and/or patients and stake-
holder preferences and condition severity. Consequently, 
all kinds of sport, physical activity, training and so on are 
recommended and patient’s preferences and fitness are 
considered the main selection criteria.9
The 2017 Clinical Guideline of the American College 
of Physicians18 gives three recommendations. Recom-
mendation 2 is: ‘For patients with chronic low back pain, 
clinicians and patients should initially select nonpharma-
cologic treatment with exercise, […] tai chi, yoga, motor 
control exercise, progressive relaxation […]. (Grade: 
strong recommendation)’. The guideline authors 
confirm that there are ‘no clear differences between 
different exercise regimens’.18
A network meta- analysis (NMA) is needed to investigate 
the comparative efficacy of different types of exercise in 
order to base recommendations on evidence and pref-
erences rather than preferences alone. To fill this gap, 
we will perform an NMA of randomised controlled trials 
(RCTs) to investigate the comparative efficacy of different 
exercise interventions compared with no specific inter-
vention or functionally inert interventions on pain inten-
sity and back- specific disability in patients with chronic 
non- specific low back pain.
Thus, this NMA will inform clinical practice to make 
the best possible choices for treating chronic non- specific 
low back pain. It will further inform future research as it 
will identify research gaps and demonstrate where further 
high- quality research is needed.
Patient and public involvement
This review protocol was developed in a consensus 
process between clinical experts, methodological experts 
and patient advocates. The review’s stakeholder advi-
sory board comprised a general practitioner and full 
professor of general medicine with longstanding expe-
riences regarding the needs, preferences and capabili-
ties of patients with chronic non- specific low back pain. 
Further, patient advocates of Germany’s biggest and most 
important pain related patient associations participated 
in the study development: the director of the German 
Patient Association Ankylosing Spondylitis and a patient 
advocate of one of Germany’s biggest patient associations 
for pain (‘SchmerzLOS e.V.’). The patient representative 
was chosen because he also served as the main patient 
representative in the recently updated German National 
Disease Management Guideline non- specific for Low 
Back Pain (‘Nationale VersorgungsLeitlinie unspezi-
fischer Kreuzschmerz’) which also exclusively focused 
on non- specific forms of low back pain9 and because 
there is no national patient organisation for patients with 
non- specific low back pain. The stakeholder board was 
involved in all levels of the protocol development such 
as choice of eligible patient groups, exercise categories, 
comparators, and especially regarding patient- relevant 
outcomes.
The results of this NMA will help to inform patients and 
their healthcare providers about the comparative efficacy 
and safety of different types of exercise in order to enable 
informed shared decision- making. Future patients will 
thus directly benefit from the results of this review.
METHODS AND ANALYSIS
This protocol is reported in compliance with the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols statement.19 The full NMA will be reported 
in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses_NMA checklist.10
Eligibility criteria
Population
This NMA will focus on patients with chronic non- specific 
low back pain.20 Studies on adults (at least 18 years) of all 
genders with non- specific low back pain of at least 12 weeks 
duration will be eligible.21 Studies including patients with 
low back pain caused by specific pathologies (eg, herni-
ated discs, fractures, ankylosing spondylitis, spondyloar-
thritis, infections, neoplasms or metastases) or conditions 
(eg, pregnancy) will be excluded as will studies that focus 
exclusively on acute exacerbations of chronic low back 
pain.10 Studies on patients with sciatica or radicular symp-
toms will only be eligible if they were diagnosed with non- 
specific low back pain. Studies including patients with a 
mixture of non- specific and specific low back pain will 
only be eligible if data on those two patient groups are 
presented separately.
3Anheyer D, et al. BMJ Open 2020;10:e036050. doi:10.1136/bmjopen-2019-036050
Open access
Interventions
Studies on exercise interventions will be eligible. Exer-
cise interventions will be defined as structured inter-
ventions planned, prescribed and delivered by a health 
professional that include conducting specific activities, 
movements, postures (or both).7 8 Studies on exercise 
on a one- to- one basis or in a group environment will be 
eligible. Studies including unstructured self- management 
or simple advice to stay physically active will be excluded. 
Studies on exercise combined with another non- exercise 
intervention (such as multimodal pain treatment) will also 
be excluded. For the purpose of this review, NICE catego-
ries for different categories of exercise were adopted8:
1. Biomechanical exercise: this category of exercise is 
primarily directed at altering or improving spinal me-
chanics and includes muscle strengthening, stretch-
ing, range of motion exercise, motor control exercise 
(eg, spinal stabilisation exercises, core stability pro-
grammes and Pilates) or programmes addressing spe-
cific movement patterns or problems (eg, McKenzie 
exercise, including directional preference exercises, 
and the Feldenkrais method).
2. Aerobic exercise: this category of exercise is primarily 
directed at improving cardiovascular fitness and en-
durance. This category includes walking, jogging, run-
ning, cycling, swimming for example.
3. Mind- body exercise: this category of exercise comprises 
a combined physical, mental and spiritual focus. This 
type often includes a focus on breathing and a medita-
tive state of mind besides movement or body positing. 
Also referred to as meditative movement.22 Examples 
include the various forms of Yoga and Tai Chi.
4. Mixed modality exercise: an umbrella category for ex-
ercise interventions that incorporate a combination of 
any of the previous three categories.
A description of the interventions based on an abbre-
viated form of the Template for intervention description 
and replication (TIDieR) checklist will be found in the 
supplement.23
Comparators
Studies comparing exercise to either no specific interven-
tion (ie, no treatment, wait- list or usual care at the treating 
physician’s discretion and according to NICE guideline8 
and the American College of Physicians guideline7) and/
or functionally inert interventions (ie, sham or attention 
control interventions) will be eligible.7 Studies comparing 
one exercise type as defined above to another exercise 
type will also be eligible.
Outcomes
In line with the recommendations by Deyo et al,24 The 
Initiative on Methods, Measurement, and Pain Assess-
ment in Clinical Trials (IMMPACT),25 the Cochrane Back 
and Neck Group21 and patient advocates, the following 
outcomes were chosen as primary outcomes:
1. Pain intensity (eg, as measured by the visual analogue 
scale for pain).
2. Back- specific disability (eg, as measured by the Roland- 
Morris Disability Questionnaire).
Secondary outcomes will include:
1. Health- related quality of life (eg, as measured on the 
36- item Short Form).
a. Physical quality of life.
b. Mental quality of life.
2. Work disability.
3. Frequency of analgesic use or the number of medica-
tions used.
4. Adverse events.
All outcomes will be assessed at short- term (less than 
3 months from randomisation), intermediate- term (3–12 
months from randomisation) and long- term (more than 
12 months from randomisation) time points.21
Design of primary studies
This NMA will only include RCTs. In order to include 
only trials that will be at least minimally clinically relevant, 
only trials with at least short- term follow- up (4 weeks from 
randomisation or longer) will be eligible.21
Information sources and search strategy
Based on NICE guidelines8 and the search strategy used 
by the Cochrane Back and Neck Group,10 the following 




3. Cochrane Central Register of Controlled Trials (CEN-
TRAL, The Cochrane Library).
4. Physiotherapy Evidence Database.
5. SPORTDiscus.
The complete search strategy for MEDLINE is shown 
in table 1.
Additionally, the following trial registries will be 
searched for all prospectively registered and ongoing 
trials:
1.  Clinicaltrials. gov (http:// clinicaltrials. gov/).
2. WHO International Clinical Trials Registry Platform 
search portal (http://  apps. who. int/ trialsearch/ 
Default. aspx).
It will be tried to identify further studies from reference 
lists of identified relevant trials or reviews. A copy of the 
full article will be obtained for each reference reporting 
a potentially eligible trial. Where this is not possible, 
attempts will be made to contact authors for them to 
provide additional information. We will search for grey 
literature in online (http://www. opengrey. eu/).
Based on prior systematic reviews and guidelines,7 8 10 a 
total of about 150 eligible primary studies are expected.
Data extraction
Data will be extracted independently by two review 
authors.26 Disagreements will be dissolved by discussion. 
If this is impossible, a third author will be approached. 
If necessary, additional information will be obtained 
from the study authors.26 The data extraction form will 
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be developed a priori and pilot tested in a representa-
tive sample of the studies to be reviewed; if necessary, 
the form will be adapted.26 Data will be extracted on 
Table 1 Complete search strategy for Medline
Main search—all dates (1946–present)
1 Lower back pain population (Search 1.1)
2 Excluded study designs and publication types (Search 
1.2)
3 1 not 2
4 exp exercise/
5 exp exercise therapy/
6 exp “physical education and training”/
7 (pilates or yoga or mckenzie or feldenkrais or swim* or 
walk* or run* or jog* or treadmill* or tread mill*).ti,ab.
8 (stretch* adj3 (active* or passive* or relax* or static* or 
dynamic* or gentl* or ballistic* or force* or isometric or 
technique* or exercis* or therap*)).ti,ab.
9 (aerobic* adj (exercise* or train* or therap*)).ti,ab.
10 ((corrective* or biomechanic*) adj (exercise* or train* or 
therap*)).ti,ab.
11 (biomechanic* adj (method* or course*)).ti,ab.
12 ((strength* or stabil* or program* or train* or therap* or 
technique* or treat*) adj3 exercise*).ti,ab.
13 (fitness* adj3 (program* or train* or therap*)).ti,ab.
14 (tai ji or tai chi or taichi or taiji or taijiquan).ti,ab.
15 (qigong or ch’i k#ng or ch’i g#ng or chi k#ng or chi 





20 exercise movement techniques/
21 exp hydrotherapy/
22 exp balneology/
23 (balneology or balneotherap*).ti,ab.
24 ((water* or bath* or pool or pools or shower* or 
underwater* or spa or spas or aqua*) adj2 (exercise* or 
train* or therap* or treat* or manag*)).ti,ab.
25 (hydrotherap* or hydro- therap*).ti,ab.
26 posture/
27 postural balance/
28 (postur* adj2 (balanc* or train* or therap* or treat* or 




31 Study filters RCT(Search 1.3)
32 3 and 30 and 31
Search 1.1—population search terms




4 ((lumbar or lumbosacral or lumbo- sacral or back) adj5 
(pain* or ache* or aching)).ti,ab.
5 (backache* or lumbago or sciatica or dorsalgia or 
coccyx or coccydynia or spondylosis).ti,ab.
6 (radiculopathy or radiculitis or radicular pain*).ti,ab.
7 (nerve root* adj5 (pain* or avulsion or compress* or 
disorder* or pinch* or inflam* or imping* or irritat* or 
entrap* or trap*)).ti,ab
8 or/6–7
9 (back* or lumbosacral or lumbo- sacral or lumbar).ti,ab.
10 8 and 9
11 or/1–5, 10
Search 1.2—search terms for excluded study designs 
and publication types
The following study designs and publication types will be 




4 exp historical article/
5 anecdotes as topic/
6 comment/
7 case report/
8 (letter or comment*).ti.
9 or/1–8
10 randomized controlled trial/ or random*.ti,ab.
11 9 not 10
12 animals/ not humans/
13 exp animals, laboratory/
14 exp animal experimentation/
15 exp models, animal/
16 exp rodentia/
17 (rat or rats or mouse or mice).ti.
18 or/11–17
Search 1.3—randomised controlled trials search terms
1 randomized controlled trial.pt.
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methods, participants, interventions and control inter-
ventions, outcomes and results. For studies with more 
than one publication, the first publication will be consid-
ered as the primary reference, but data will be extracted 
from all publications. Post- treatment assessments will be 
extracted and analysed. If only change from baseline data 
is reported, authors will be contacted.
Risk of bias in individual studies
Two review authors will assess risk of bias independently. 
Disagreements will be handled as outlined above. Risk 
of bias will be assessed using the recommendations by 
the Cochrane Back and Neck Group21 and be based on 
an adaptation of the Cochrane Risk of Bias tool.26 Risk 
of bias is assessed on 13 items from 6 domains: selec-
tion bias (adequate random sequence generation, 
allocation concealment, group similarity at baseline), 
performance bias (blinding of participants, blinding of 
personnel/providers, similar cointerventions, accept-
able compliance), attrition bias (acceptable drop- out 
rate, intention- to- treat analysis), detection bias (blinding 
of outcome assessors, similar timing of outcome assess-
ment), reporting bias (no selective outcome reporting) 
and other bias. Each item is rated as either low risk of bias 
if requirements are adequately fulfilled, high risk of bias 
if requirements are not adequately fulfilled or unclear 
risk of bias if data provided are insufficient for a judge-
ment.21 26
Data analysis
According to NICE guidelines and recommendations 
by Cochrane, this NMA will be planned and calculated 
based on a Bayesian approach.26 After making model- 
based choices, further diagnostic processes must be 
undertaken to verify if the model was appropriate. These 
approaches must assess heterogeneity and inconsistency, 
two assumptions underlying any NMA that are highly 
influential to the results. First, a pairwise meta- analysis 
will be performed by using R software, V.3.3 (R Founda-
tion for Statistical Computing, Vienna, Austria. https:// 
cran. r- project. org) to check for consistency and to eval-
uate statistical heterogeneity. Therefore, τ2 and I2 statis-
tics will be applied to quantify the extent of between- trial 
heterogeneity and variability. To test their stability, the 
results of the random- effects model will be compared 
with that of the fixed- effects model. ORs with 95% CIs 
will be calculated for dichotomous variables, while mean 
difference (MD) with 95% CI will be estimated for contin-
uous variables.
Where different instruments were used to measure the 
same outcome, standardised MDs and their 95% CIs will 
be calculated and re- expressed as MDs by multiplying 
them by the pooled SD of the baseline scores, either from 
available epidemiological studies or from the largest 
related RCT using the same measurement instrument. 
Pain, back- specific disability and quality of life will be 
re- expressed on an 11- point numerical rating scale, the 
Roland- Morris Disability Questionnaire and the SF-36, 
respectively.21 26 27
Second, NMA will be conducted using a Bayesian 
Markov Chain Monte Carlo (MCMC) framework and 
fitted in R V.3.3 software (https:// cran. r- project. org/ src/ 
base/ R- 3/) via the gemtc V.0.82 package.
Network geometry
In a first step of the NMA the geometry of the expected 
treatment network will be evaluated. Therefore, a graph-
ical network diagram will be created and explored. 
Comparison- adjusted funnel plots will be applied to 
visually assess the presence of small- study effects in the 
network. Funnel plots in an NMA account for the fact 
that studies evaluate treatment effects for different 
comparisons.28
Heterogeneity
Assessment of the statistical heterogeneity in the entire 
network will be based on the magnitude of the common 
τ2 estimated from the NMA models.29 30
Prior selection, model fit and inconsistency
Decisions about priors will be based on geometry, asym-
metry and heterogeneity of the treatment network. Addi-
tionally recommendations made by Copas and Shi31 will 
be taken into account. To check whether a model’s fit is 
satisfactory, the posterior mean residual deviance will be 
calculated.32 Furthermore, we will compare fixed- effect 
and random- effect models using the deviance informa-
tion criterion. Consistency will be evaluated by comparing 
the model fit from a consistency model with that from 
an unrelated mean effect model33 and by comparing 
direct evidence from pairwise meta- analysis with indirect 
evidence using the node- split approach.34
Data synthesis
Statistical inference will be based on 150 000 iterations 
of MCMC after a 50 000 iterations burn- in period by 
running four chains simultaneously.35 The distributions 
of the parameter will be summarised by their median (OR 
or MD) and 95% credible intervals (CrIs). Additionally, 
trace plots and Brooks- Gelman- Rubin diagnostic plots 
will be used to assess convergence. A Gaussian model will 
be used for continuous variables and a Bernoulli model 
will be used for dichotomous variables.
Posterior rank probability estimation
To support the decision- making process, the rank proba-
bility for every treatment option is estimated in a secondary 
analysis. In addition to the rank probabilities the surface 
under the cumulative rank curve will be estimated. Due to 
a risk that the ranking probabilities are falsely highlighted 
as clinically meaningful, while the treatment effects are 
statistically non- significant or very small, they will only be 
interpreted against the background of their respective 
95% CrIs.36
Handling of missing data will be conducted according 
to the Cochrane Handbook for Systematic Reviews.26
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The clinical relevance of MDs will be assessed by 
comparing them against established minimal clinically 
important differences for the respective measurement 
instrument.27
Subgroup and sensitivity analyses
Based on Cochrane methodology10 and the recommenda-
tions of the review’s stakeholder advisory board, subgroup 
analyses will be conducted for:
1. Type of participants: less than 65 years of age versus 65 
years or older.
2. Type of delivery: home exercise versus supervised 
group exercise versus supervised individual exercise.
3. Intervention dose/intensity: total intervention time be-
low 150 min per week versus above 150 min per week.
Sensitivity analyses will be conducted for:
1. Studies with low versus high or unclear risk of selection 
bias.
2. Studies with low versus high or unclear risk of detec-
tion bias.
3. Studies with low versus high or unclear risk of attrition 
bias.
4. Studies whose exercise interventions used warm- up ex-
ercises versus used no warm- up exercises.
Given that analgesics use is a highly relevant effect 
modifier in low back pain research, a meta- regression will 
be performed to investigate the influence of analgesics 
use on study results. The following subgroup analyses will 
be carried out:
1. Data on analgesics and other cointerventions use are 
available versus data on analgesics and other cointer-
ventions use are not available.
2. Analgesics and other cointerventions use was allowed 
versus analgesics and other cointerventions use was 
prohibited.
3. Analgesics and other cointerventions use was compara-
ble between groups versus analgesics and other coint-
erventions use differed between groups.
Quality of evidence
Based on the methodological quality and the confidence 
in the results, the quality of evidence from direct compar-
isons will be graded according to the Grading of Recom-
mendations Assessment, Development and Evaluation 
(GRADE) recommendations and their extension for 
network meta- analyses37 38 as:
1. High quality: we are very confident that the true effect 
lies close to that of the estimate of the effect.
2. Moderate quality: we are moderately confident in the 
effect estimate: the true effect is likely to be close to the 
estimate of the effect, but there is a possibility that it is 
substantially different.
3. Low quality: our confidence in the effect estimate is 
limited: the true effect may be substantially different 
from the estimate of the effect.
4. Very low quality: we have very little confidence in the 
effect estimate: the true effect is likely to be substantial-
ly different from the estimate of effect.
The quality of evidence will be downgraded due to 
concerns regarding risk of bias, inconsistency, indirect-
ness, imprecision and publication bias.
The rating of quality of evidence from indirect compar-
isons will be based on the lower quality rating of the two 
direct comparisons, which are used in the indirect compar-
ison (ie, A vs C and B vs C for the indirect comparison A 
vs B). The quality of indirect comparisons might further 
be downgraded due to intransitivity (differences between 
trials on interventions that are indirectly compared).
If both direct and indirect evidence is available for a 
specific comparison, the higher quality rating will be used 
to rate the quality of evidence of the NMA.30
ETHICS AND DISSEMINATION
In order to make the results of this NMA as widely available 
within the scientific community as possible, it is planned 
to publish the results in a high- ranked peer- reviewed 
medical journal that grants immediate open access. It is 
further intended to present the results on international 
scientific conferences and meetings.
We expect that the trial results will be transferred to 
routine medical practice after scientific evidence- based 
publication. The applicants will enhance the dialogue 
between physicians and physical therapists and have 
established an expert network and provide information 
for researchers and patients (conferences, meetings, 
internet and consultation). Furthermore, after receiving 
approval from the sponsor of the study, a press release 
will be issued covering key aspects of the meta- analysis’ 
results. A press conference may also be considered in this 
context. Articles summarising the findings and implica-
tions of this meta- analysis will be submitted to journals 
targeting general physicians, clinical specialists, physical 
therapists and/or patients.
The results of the trial will be implemented in existing 
national and international guidelines and will be 
presented to healthcare providers and decision makers.
According to German guidelines, no ethical approval 
is needed as analyses are secondary analyses and all data 
were de- identified and analysed anonymously.
The planned completion date of the study is 1 July 2021.
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